Condition
Hematologic Disorders clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hematologic Disorders clinical trials that are recruiting, at sites in 2 countries (most in China (1), United States (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Lusutrombopag to help platelet recovery after allogeneic stem cell transplant
This will test whether the oral drug lusutrombopag helps restore platelet counts in adults after HLA haploidentical allogeneic stem cell transplantation for blood disorders.
-
Second or greater stem cell transplant using reduced intensity conditioning
This study is testing a gentler approach to give a second or more stem cell transplant to patients with blood disorders who didn't get enough benefit from their first transplant to see if it helps them recover better.
Related topics
Quick answers
How many Hematologic Disorders clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.